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Abstract
Background: Currently available molecular method to detect HER2I655V polymorphism such as PCR-RFLP is hampered
by the costly experimental method, and post-PCR treatment requirement that makes this technique is not meeting for
high-throughput analysis purpose. In this study, we developed an accurate, simple, low cost and rapid test to detect
polymorphism at HER2 gene using SBR Green I based-melting curve method. Methods: Two forward allele-specific
primers and one common reverse primer were used then these primers were tested to discriminate known genotypes of
genomic templates (GG type or AA type) and genomic samples retrieved from breast cancer patients. Results: Melting
curve analysis derived from SYBR Green I-based allele-specific PCR with defined primers concentration and annealing
temperature at 54.3 °C showed good discrimination level of Tm peaks in which GG genotype melted at 89 °C slightly
higher than AA genotype which melted at 86 °C, while AG genotype harbored both of homozygous Tm characteristics.
Conclusions: This preliminary result will be as basic for further large-scale typing of HER2I655V polymorphism.
Keywords: breast cancer; HER2, polymerase chain reaction, polymorphism, SYBR Green I

domain of the HER2 protein.9 This amino acid changing
mainly isoleucine to valine was presumed to increase the
ability of breast cells to transform through receptor
activation by mimicking ligand induction.10 Indeed,
case-control study conducted by Xie, et al.11 in Chinese
women population highlighted the role of HER2
polymorphism as a susceptible biomarker for breast
cancer risk. Women whose HER2 contains Val
(GTC)/Val (GTC) or Ile (ATC)/Val (GTC) variant tend
to have more breast cancer risk than its wild variant.12
Independent studies also strengthen how this allelic
imbalance significantly contribute to breast cancer
development.13

Introduction
Breast cancer, the second leading cause of cancer-related
death for women, has become global health concern
with almost 1.5 million women were diagnosed where
one-third died due to this illness.1 It is estimated that the
incidence rate of breast cancer will further increase due
to ‘westernised’ lifestyle adaptation in many developing
countries.2 For many years, efforts have been conducted
to elucidate the risk factors that contribute to breast
tumorigenesis. Nowadays, it was established that
environmental and genetic factors are the major keys
that implicate to breast cancer risk.3,4 Indeed, much of
studies have clearly shown how the aberrant genetic
factors could induce carcinogenesis in the breast,
indicating the accumulative effect of such event that
collectively increases breast cancer risk.5

Predicting the types of HER2I655V polymorphism precisely
in a population will significantly impact not only on the
development of antibody-based anticancer drugs but
also improvement of the care quality for breast cancer
patients. Currently, a commonly available method with
routine use for detecting HER2I655V polymorphism in
breast cancer is Polymerase Chain Reaction-Restriction
Fragment Length Polymorphism (PCR-RFLP).11,13-15
Although this method offers superiority in term of sensitivity,
and specificity yet post-PCR processing step such as digesting
enzyme treatment and agarose electrophoresis to visualise the
result is mandatory before the data could be retrieved.16 These
additional steps of method cause the analysing more
costly and most importantly that it will be a time-

Elucidating the genetic predisposition of breast cancer
risk has risen the importance of genetic variants named
single nucleotide polymorphisms to breast cancer
development and progression.6 One of the genes that
contains genetic variant whose function in breast cells is
very significant named HER2.7 It is believed that the
aberrant of this oncogenic gene leads breast cells to
uncontrol growth and tumour induction.8 Genetic
variant of this gene is exclusively found at codon 655
(isoleucine or valine) located at the transmembrane
29

August 2016 | Vol. 20 | No. 2

30 Budiarto, et al.

consuming procedure. Moreover, an involvement of
cancer-inducing agent such as ethidium bromide during
visualising steps further brings the additional issue such
as safety aspect for laboratory workers.
To be considered as standard tools for diagnostic
purposes, a method must be accurate, cost effective, and
fast enough to allow the automated testing of large
numbers of samples without omitting its sensitivity,
specificity, reproducibility, precision, and high-throughput
capability.17 The invention of real-time PCR the machine
has open widely to the new area of method developing for
polymorphisms detection.18 Indeed, such multiplex-based
real-time PCR usually involves no/less-carcinogenic
dyes such as SYBR Green I as a labelling agent.19 This
automated assay could be performed due to melting curve
analysing is based on differentiating double-stranded
from single-stranded DNA by changes in fluorescence
intensity in the present of DNA-binding dyes at melting
temperature condition.20,21 Although, application of such
SYBR Green I-based melting curve analysis has been
widely applied in the variety of molecular diagnostics,2227
yet studies related to the application for HER2I655V
polymorphism detection especially in the case of breast
cancer experiment, no reports have been published.
In this study, we developed the HER2I655V genotyping
assay by integrating allele-specific PCR with melting
curve analysis using SYBR Green I, avoiding subsequent
post-PCR treatments hence far from chemical and
physical dangers. This technique also provides multiplex
genotyping assay in the single tube format with accurate,
rapid and inexpensive cost, allowing high-throughput
HER2I655V is genotyping.

Methods
Samples collection and genomic DNA extraction. Ten
tissue samples of 10 breast cancer patients were collected
from M. Djamil Padang hospital, West Sumatra province
as frozen section sample. Genomic DNA were extracted
using Pure Link Genomic DNA Mini Kit (Invitrogen,
Thermo Fisher Scientific Inc., America) followed manual
instruction using 10-20 mg of tissue as starting material
to be extracted while plasmid extraction was extracted
from overnight culture of recombinant Escherichia coli
DH5α (collection of Molecular Biology and Diagnostics
Laboratory, Research Center for Biotechnology-LIPI)
using high Speed Plasmid Mini Kit (Geneaid Biotech
Ltd. Taiwan) followed manual instruction with 30 µl of
ddH2O applied to elute recombinant plasmid. The
integrity of all genomic DNA was checked using 0.8%
agarose and the DNA content was also measured using
spectrometer (Gene Quant TM Pro RNA/DNA calculator,
GE Healthcare Biosciences). Two genomic DNA and
pGEM_HER2/AA with known their genotype were also
prepared. Their polymorphisms have been checked using
Sanger sequencing and allele-specific PCR.28 For all
Makara J. Health Res.

subject enrolled in this study was approved by local ethics
committee issued from Ministry of Health, Republic of
Indonesia.
Sensitivity test of Allele-Specific PCR. This test was
done using PCR supermix reagent purchased from
Invitrogen. The composition for each PCR components
followed the instruction except primers; we used 200
pmol each. Two specific allele primers with forwarding
direction (HER2_GG: 5'GCGGGCAGGGCGGCGGGG
GCGGGGCC-CCAGCCCTCTGACGTCCACCG'3 and
HER2_AA: 5'CCAGCCCTCTGACGTCCAGCT'3) and
one common reverse primer (HER2_R:5'CGTGTACTT
CCGGATCTTCTGCTG'3) were used followed methods
Bui, et al.,29 and Germer and Higuci.30 The Genomic DNA
(182 ng/µL stock) with GG genotype and pGEM_HER2
(182 ng/µL stock) with AA genotype were used as a
template. Serial dilution was done 10 to 100 times from
each stock then mixed to create genomic DNA that
contains both of genotype that mimics AG genotype in
nature. Amplification condition consisted of a 5 minutes
pre-incubation period at 95 °C, followed by 35 cycles of
denaturation at 95 °C for 30 seconds, primer annealing
carried out for 1 minutes at 51.5 °C and extension were
at 72 °C for 30 seconds. The PCR product was checked
on 2% of gel agarose.
HER2I655V genotyping using SYBR Green I and melting
curve analysis. This analysis was done using CFX96
Real-Time PCR (Biorad Laboratory Inc, USA). Primers
concentration applied in this experiment followed
formulation as suggested by Darawi, et al.31 Allele-specific
PCR composition for each reaction was 10 µL for final
volume of each reagent as followed: 1x SsoAdvance
Universal SYBR Green Supermix, 0.06 pmol HER2_GG
primer, 0.1 pmol HER2_AA, 0.15 pmol HER2_R, DNA
template at the range of 0.07-0.158 ng and the rest is
dH2O to gain the final volume of 10 µL as stated in the
kit except for primers concentration it was modified
slightly.Allele-specific PCR amplification profile was as
follows: initial denaturation at 95 °C for 5 minutes,
followed by 35 cycles of denaturation at 95 °C for 20
seconds, temperature annealing at 54.3 °C, for 20 seconds,
and extension at 72 °C for 30 seconds. The fluorescence
melting curve was analysed immediately following
amplification. After amplification, the fluorescence
intensity of the PCR product was measured from 65-95
°C with 0.5 °C/cycle increment. One sample PCR
reaction with no contain DNA was also included in the
experiment to clarify PCR contamination.

Results
Firstly, the sensitivity of the method was evaluated
especially in the case of heterozygote (AG type) using a
mix of two genomic DNA template with known
genotype by dilution from 10 up to 100 times. The
August 2016 | Vol. 20 | No. 2
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effect of DNA template dosage followed inversely the
ratio of DNA amount added with 100 dilution factor
exhibiting the best polymorphism discrimination as
marked by the appearance of two allele-specific PCR
product sizes which referred to AA type and GG type
(Figure 1).
The melting curve analysis for each corresponding
HER2I655V genotypes showed that GG genotype exhibits
Tm value slightly higher than AA genotype while AG
genotype produces two different Tm values that refer to
each of homozygote type (Figure 2). The extra poly-GC
on a primer that was amplified as GG genotype produce
higher of GC content that impacts directly on its Tm
value and PCR product stability.
To confirm the ability of method in detecting poly-morphism,
10 samples of breast cancer patient with unknown their
HER2I655V polymorphism were enrolled with three
replication to ensure reproducibility of the assay. The
integrity and quantity of the genomic DNA vary but overall
that genomic DNA is acceptable to be used in method
confirmation (Figure 3).
Tm curve analysis on 10 samples tested showed that 50% of
samples belong to AA genotype while another half were AG
genotype. No GG type was observed from 10 samples tested
(Figure 4). Comparing this result with another established
method such as Sanger sequencing, allele-specific Tm curve
method exhibited closely 100% accordance among genotype
tested, except for one sample

Figure 2. Tm Values for Each Type of HER2I655V Polymorphism

Figure 1. Allele-specific PCR Result of each HER2I655V
Genotype. Lane 1; 100 bp of DNA Ladder, Lane
2; Genomic DNA with GG Genotype (182 ng/µL
stock), Lane 3; Genomic DNA with AA Genotype
(182 ng/µL stock), Lane 4; mix of 2 and 3 after
10 Time Dilution, Lane 5; mix of 2 and 3 after
100 Time Dilution. Red Arrow and Blue Arrow
Sequentially Refers to GG Type (166 bp) and
AA Type (116 bp)
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Figure 3. Genomic DNA Extraction Result from 10 Samples
of Breast Cancer Patients
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observed on agarose seems imbalanced. Other factors
such as the concentration of MgCl2, the unit of Taq
polymerase and the proportion of primers concentration
added into PCR solution are also the essentials
substance that determines the success of polymorphism
detection using allele-specific PCR.33

Figure 4. Melting Curve Analysis of HER2I655V Polymorphism from 10 Samples of Breast Cancer
Patients. Red Line showed Samples with AA
Type; Green Line showed Samples with AG Type
while NTC (Non-Template Control) was Pointed
by Black Line. The Number of Replicate for Each
Sample is 3 Times

Table 1. Comparison Result of Melting Curve with
Established Genotyping Method

Samples positivity
(% distribution)

HER2I655V
Genotypes

Melting curve
method

Sanger sequencing
method

AA

5 (50%)

5 (50%)

GG

-

1 (10%)

AG

5 (50%)

4 (40%)

Total

10 (100%)

10 (100%)

showed AG genotype by this method but presenting GG
genotype based on Sanger sequencing, indicating there
was a minor difference between methods as result of
dissimilarity in their detection sensitivity level (Table 1).

Discussion
The success of genotyping analysis using allele-specific
PCR relies on how good enough each of specific PCR
products could be differed clearly on gel agarose without
producing an ambiguous interpretation. Due to the
nature of specific primers designed in this method, the
preferential amplification of one of the alleles may occur.
As mentioned by von Ahsen, et al.32 The genotyping of
heterozygous samples requires special consideration due
to the present both of allelic types in a single sample,
reducing the amount of template is one of an alternative
way to increase the probability of minor allele to be
amplified equally during PCR reaction. Although the
AG genotype could be well discriminated using this
method, yet the thickness of the two PCR products
Makara J. Health Res.

We have observed that two genotypes exhibited distinct
Tm curve profile where GG genotype showed 3 °C higher
of Tm value compared with AA genotype although the
single peak of specific Tm was only observed in AA
genotype. The peaks and its sharpness among genotypes
observed on melting curve profile will solely depend on
their GC content, sequence length, type of dyes, the
concentration of primers annealing temperature of primers
and dosage of DNA template used.6,31,34-36 The important
point to be highlighted in this result is that the two
peaks between two different genotype still could be seen
clearly event though the DNA dosage used in PCR
solution is low, Indicating the melting curve method
improves the sensitivity of genotype detection. Marin, et
al.37 have observed that allele-specific PCR produces a
missing result as much as 20-21% while only 1.3% had
missing by melting curve analysis. Moreover, they also
suggest that to obtain the similar pattern and well
discriminated of melting peaks for each genotype, the
use of 3-25 ng of genomic DNA as a template in allelespecific PCR recommended. The unspecific peak that
arises below 80 °C of Tm value is primer dimer due to
too low annealing temperature applied in PCR process.
This similar event was observed in another study that
stated low annealing temperature used in genotyping
human rotavirus generates unspecific PCR product
whose Tm is below 77 °C.38 We predicted that our method
improvement in this study is related to the proportion of
primers concentration and annealing temperature applied
beside DNA dosage usage.
The choice of molecular methods for gene polymorphisms
studies must consider several aspects of methods
feature, and usually, methods with high sensitivity,
specificity, reproducible, robustness, and low-cost are
the most researchers used. Beside specific enzymes
restriction-based PCR, another method that currently
applied for polymorphisms studies is probe-based RealTime PCR due to high specificity detection produced.39,40
Nevertheless, such methods require additional primer
design that contains costly specific probe that hampers to
diagnostics purpose with prerequisite low-cost
technology. In our study, we have improved allelespecific PCR for HER2I655V polymorphism detection
using DNA binding agent such as SYBR Green I dye in
PCR-ready used format. This strategy with optimised
PCR condition (suitable primers ratio, DNA template
dosage, and short DNA target) have been proven to be
well performed in discriminating each of HER2I655V
without any further additional chemicals agent such as a
probe. One particular caution in applying SYBR Green
August 2016 | Vol. 20 | No. 2
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I-based melting curve method for poly-morphisms
studies should keep in mind that the DNA target must
be 50-200 bp in length to prevent unspecific binding of
the dye due to influence of dye concentration and DNA
dosage used.6,35,41

HER2I655V polymorphism in breast cancer. This
preliminary result will be a basic for further large-scale
HER2I655V genotyping in breast cancer.

Another important issue regarding single nucleotide
polymorphisms studies using DNA binding dye-based
Tm shift genotyping method is possibility occurrence of
variety in Tm values for the same genotype due to the
different in PCR instruments usage. This event have
been observed in genotyping study of sickle cells
anemia-related genes using High Resolution DNA
Melting Analysis (HRMA) where the resolution of the
melting curve varied among PCR instruments tested,
with a 15-fold difference in Tm SD (0.018 to 0.274 °C)
and 33 fold (SYBR Green I) difference in the signal-tonoise ratio.42 Based on this finding, the Tm values of each
HER2I655V genotype obtained in our study may produce
slight different Tm value when another type of PCR
instruments applied, yet the predicted Tm values will
probably be around at 85.98-86.27 °C for AA genotype
and at 88.92-89.27 °C. for diagnostics purpose, we strongly
recommended for the user to do a comparison study of
different PCR instruments before the real test done.

The authors declare that they have no conflict of
interest.

The allele frequency of genes in genotyping studies is a
very important aspect to obtain the solid conclusion in
term of SNP association to some diseases. We have
shown that allele-specific PCR in our study is as good
as Sanger sequencing in HER2I655V polymorphism
detection. Both of methods produce the same allelic
frequency distribution which is 0.5 for Ile (AA
genotype) and 0.5 for Val (AG combined with GG
genotype). However, Xie, et al.11 obtained values which
are 0.84 for Ile and 0.16 for Val from 339 patients with
breast cancer from a Chinese population. This
discrepancy probably due to the small size of sample
enrolled in our study. Keshava, et al.7 found that the
frequency allelic of HER2I655V varied significantly by
race. This is the limitation of our study which used only
10 DNA samples of breast cancer. Further study needs to
be conducted using adequate samples, adding more
breast cancer samples to comply statistics prerequisite
to clarify and validate our result. Melting curve method
has been applied successfully to detect a
BDNFVal66Met polymorphism,41 chicken Mx gene
G2032A SNP, and GSTT1, and GSTM1 null
polymorphism.37 Overall, this result showed that melting
curve method in our study well performed to
discriminate each type of HER2I655V polymorphism in
breast cancer.

Conclusions
SYBR Green I-based melting curve method has been
developed with success, and it well performed to detect
Makara J. Health Res.
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